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Over the past years, echocardiography and magnetic
resonance imaging (MRI) have become important
imaging modalities in patients with a broad spectrum
of cardiomyopathies [1–20]. Both imaging modalities
have been shown to play a pivotal role in the accurate
evaluation of left ventricular function particularly in
patients with ischemic heart disease and different
forms of cardiomyopathy [21–36]. These methods are
needed to accurately identify and characterize patients
with various manifestations of left ventricular hyper-
trophy (LVH) [37–49]. The important question should
be resolved whether training-induced LVH in athletes
is a physiological rather than a pathophysiological
phenomenon [50–57]. In a meta-analysis using MRI,
involving 59 studies and 1,451 athletes (both endur-
ance-trained and strength-trained athletes), it was
reported that the athlete’s heart demonstrated normal
systolic and diastolic cardiac function, implying that
training-induced LVH in athletes is predominantly a
physiological phenomenon [58]. With respect to
echocardiography,two-dimensionalstrainhasbecome
a novel method to measure strain from standard two-
dimensional echocardiographic images by speckle
tracking. Speckle tracking offers the advantage of
being less angle-dependent and more reproducible
than conventional Doppler-derived strain [59–61].
This echocardiographic imaging technique allows
quantiﬁcation of global and regional myocardial
deformation on the basis of tracking of acoustic
markers from frame-to-frame.
In the current issue of the International Journal of
Cardiovascular Imaging, Butz et al. [62] questioned
whether two-dimensional strain assessed by speckle
tracking was useful as an additional tool in differen-
tiating pathologic from physiologic LVH in high-level
athletes. The objective of the study was to identify and
characterize global and regional function abnormali-
ties in patients with pathological left ventricular
hypertrophy (LVH) caused by non-obstructive hyper-
trophiccardiomyopathy(HCM),inhigh-levelathletes,
and in healthy controls. The authors consecutively
studied53subjectsconsistingof15patientswithHCM
and 20 competitive top-level athletes. A control group
of 18 sedentary normal subjects was studied by
standard echocardiography according to standard
guidelines. Global longitudinal strain and regional
peak systolic strain were assessed by two-dimensional
strain in the apical four-chamber view. It turned out
that all components of strain were signiﬁcantly
reduced in patients with HCM when compared to
athletes and control subjects. There was no signiﬁcant
difference between thestrainvaluesofthe athletes and
the control group, but in some segments the strain
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than those in the athletes. A cut-off value of global
longitudinal strain less than -10% for the diagnosis of
HCM resulted in a sensitivity of 80% and a speciﬁcity
of 95%. The combination of tissue Doppler imaging
(averaged S0,E 0) and global longitudinal strain cut-off
values for the detection of pathologic LVH in HCM
demonstrated asensitivity of100% anda speciﬁcityof
95%. The authors concluded that speckle tracking is a
new simple and rapid method to measure global
longitudinal strain and peak systolic strain as compo-
nents of systolic strain.
This novel and very interesting technique offers a
unique approach to quantify global as well as regional
systolic dysfunction, and might be used as new
additional tool for the differentiation between physi-
ologicandpathologicLVH.Thepresentstudyisoneof
the ﬁrst that used the combined and comprehensive
tissue Doppler imaging analysis of systolic and early
diastolic velocities of the lateral and septal mitral
annulus as well as two-dimensional strain analysis for
thedifferentiationbetweenpathologicandphysiologic
LVH. The main results of this intriguing study show
that global strain is signiﬁcantly reduced in patients
with HCM and that strain measurements can therefore
be used for differentiation between pathologic and
physiologic LVH. Especially, the combination of
tissue Doppler imaging and two-dimensional strain
assessmentallowsthedifferentiationofpathologicand
physiologic LVH with acceptable sensitivity and
speciﬁcity. This differentiation is extremely important
in terms of clinical well-being, treatment and progno-
sis. In physiologic hypertrophy, such as in athletes,
LVH reveals normal circumferential, radial, and
longitudinal proﬁles possibly indicating that myocar-
dial strain imaging might be useful as additional
echocardiographic modality for the differentiation
between athlete’s heart and HCM. In pathologic
hypertrophy, LVH appears to be associated with
subendocardial ﬁbrosis, which might be a potential
mechanism for the failure of the hypertrophied myo-
cardium in due time. In another study by the same
group [63], peak systolic longitudinal strain of the
basal septum and the opposite lateral wall was
measured in addition to standard echocardiography
in 88 consecutive patients with obstructive HCM who
underwent a septal ablation procedure. Regional
myocardial deformation was assessed quantitatively
by speckle tracking. During a 12-month observation
period, no patient had a severe adverse event. Reduc-
tion of left ventricular afterload by elimination of the
outﬂow gradient followinga successful septal ablation
procedure resulted in improvement of systolic lateral
longitudinal function in patients with obstructive
HCM.
To summarize, two-dimensional strain analysis
by echocardiography is a new simple, rapid, and
reproducible method to measure systolic strain.
Echocardiographic speckle tracking allows accurate
quantitative assessment of regional myocardial defor-
mation. As a result, the speckle tracking technique
can be used as additional tool for (1) a comprehensive
cardiac evaluation in subjects with physiologic
hypertrophy versus pathologic hypertrophy, and (2)
an appropriate assessment of the effects of therapy in
patients with pathologic LVH.
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